Skip to main content
Figure 5 | Journal of Experimental & Clinical Cancer Research

Figure 5

From: Potential prognostic marker ubiquitin carboxyl-terminal hydrolase-L1 does not predict patient survival in non-small cell lung carcinoma

Figure 5

UCH-L1 expression in H838 cells confers apoptotic resistance measured by flow cytometry and PARP cleavage. A. Comparison of cell cycle analysis of propidium iodide stained untreated H838 cells (Panel i), scrambled siRNA-treated H838 cells (Panel ii) and H838 cells treated with UCH-L1 siRNA (Panel iii). The percentage of cells in sub G1/G0 are shown above each panel. B. The percentage of cells in sub G1/G0 phase of the cell cycle in each treatment group for 3 independent experiments are shown graphically. C. Immunoblot showing PARP cleavage in siRNA-treated and parental H838 cells.

Back to article page